Literature DB >> 3056033

Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs.

I K Martin1, K M Weber, R C Boston, F P Alford, J D Best.   

Abstract

Effects of four- to fivefold elevations of epinephrine (EPI) on glucose (Glc) metabolism were assessed in eight dogs before and after an intravenous Glc tolerance test, performed 30 min (short EPI) and 72 h (long EPI) after start of EPI infusion. Short EPI increased plasma nonesterified fatty acids (NEFA; 0.46 +/- 0.08 to 0.78 +/- 0.12 mmol/l, P less than 0.05), but Glc and insulin were unchanged. After long EPI, NEFA returned to control but Glc increased from 5.1 +/- 0.1 to 5.7 +/- 0.2 mmol/l (P less than 0.05). EPI reduced overall Glc tolerance (KG) from 3.5 +/- 0.7 to 2.5 +/- 0.2 (short EPI, P less than 0.05) and 2.3 +/- 0.3%/min (long EPI, P less than 0.02). Minimal model analysis showed that short EPI decreased insulin sensitivity (SI) from 7.9 +/- 1.1 to 4.2 +/- 1.2 min-1 per mU/l X 10(-4) (P less than 0.005) and increased pancreatic responsiveness (phi 1 from 3.7 +/- 0.3 to 7.4 +/- 2.9 mU/l.min-1 per mg/dl, P less than 0.025; phi 2 from 2.6 +/- 0.7 to 4.9 +/- 1.2 mU/l.min-2 per mg/dl). After long EPI SI, phi 1, and phi 2 returned to control. In contrast, Glc-mediated Glc disposal (SG) was decreased from 3.5 +/- 0.5 X 10(-2) to 2.8 +/- 0.6 X 10(-2) (short EPI) and 1.3 +/- 0.6 X 10(-2) min-1 (long EPI, P less than 0.02). We conclude that prolonged infusion of EPI leads to adaptation to its acute effects on NEFA, SI, phi 1, and phi 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056033     DOI: 10.1152/ajpendo.1988.255.5.E668

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820

Review 2.  Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment.

Authors:  Corey J Leinum; John M Dopp; Barbara J Morgan
Journal:  Nutr Clin Pract       Date:  2009-12       Impact factor: 3.080

3.  Contrasting action of short- and long-term adrenaline infusion on dog skeletal muscle glucose metabolism.

Authors:  M J Christopher; M W Sleeman; F P Alford; J D Best
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

4.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Alterations in Glucose Disposal in Sleep-disordered Breathing.

Authors:  Naresh M Punjabi; Brock A Beamer
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

6.  Effects of sleep fragmentation on glucose metabolism in normal subjects.

Authors:  Katherine A Stamatakis; Naresh M Punjabi
Journal:  Chest       Date:  2009-06-19       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.